Lumicell Pivotal (Breast Cancer) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn better ways to make sure all of the cancer is removed during surgery and to lower the chance that more surgeries will be needed.

What is the Condition Being Studied?

Breast Cancer

Who Can Participate in the Study?

Adults:
- Diagnosed with breast cancer or ductal carcinoma in situ (DCIS)
- Scheduled for a lumpectomy for a breast malignancy.

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Get a shot into your vein of the study drug (LUM015) before your surgery
- Have your tumor area scanned with the Lumicell device

Study Details

Full Title
PIVOTAL STUDY OF THE LUM IMAGING SYSTEM FOR ASSISTING INTRAOPERATIVE DETECTION OF RESIDUAL CANCER IN THE TUMOR BED OF FEMALE PATIENTS WITH BREAST CANCER
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00102180
NCT: NCT03686215
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698